Recent studies have demonstrated neuroinflammation and increased cytokine levels are associated with depression. Aware of the efficacy the potential anti-inflammatory and antioxidative activity of proanthocyanidin, the present study was designed to investigate the effects of proanthocyanidin on lipopolysaccharide (LPS)-induced depressive-like behavior in mice. In depressive behavior tests, the immobility time of forced swimming test (FST) and tail suspension test (TST) was increased when mice were administrated a single dose of LPS (0.83 mg/kg, i.p.), whereas these alterations were reversed by proanthocyanidin treatment (80 mg/kg, p.o.). In anxiety behavior tests, all the anxiety-related parameters, such as number of buried marble, time spent in the open arm and close arm did not show statistical differences between LPS and control groups. However, anxiolytic effects were observed in marble-burying test and elevated plus maze test in single proanthocyanidin treatment and proanthocyanidin treatment together with LPS group. Further assays indicated that LPS-induced overexpression of pro-inflammatory cytokines in the hippocampus, prefrontal cortex (PFC) and amygdala were reversed by proanthocyanidin treatment. Furthermore, proanthocyanidin inhibited the LPS-induced iNOS and COX-2 overexpression, via the modulation of NF-κB in the hippocampus, PFC and amygdala. Taken together, proanthocyanidin may be an effective therapeutic agent for LPS-induced depressive-like behaviors via its potent anti-inflammatory property.
Introduction
For years, accumulating evidence reveals that neuroinflammation plays an important role in the pathophysiology of depression (Miller and Raison, 2015; Krogh et al., 2014) . Recently, studies found that neuroinflammation in patients with depression were characterized by the release of proinflammatory cytokines (IL-1β, IL-6 and TNF-α) and nuclear factor-kappaB (NF-κB) activation (Monje et al., 2011; Koo et al., 2010) . Similar results had been demonstrated in some animal models as well. These animals exhibited depressive like behavior, with high expression of inflammatory mediators and increased nitric oxide synthase (iNOS) level in the prefrontal cortex (PFC) and hippocampus (Janssen et al., 2010; Hannestad et al., 2011; Chen et al., 2016) . Therefore, prevention of inflammatory disturbances has been acknowledged as a potential avenue for treatment of depression.
As the lipoglycans and endotoxins, Lipopolysaccharides (LPS) induces a strong response from normal animal immune systems. The acute administration of cytokine inducer LPS is a widely-accepted animal model to investigate the relationship between neuroinflammation and depressive symptoms (Mello et al., 2013; Wang et al., 2014; Xi et al., 2016) . Furthermore, some studies revealed that LPS-treated mice exhibited abnormal expression of pro-inflammatory cytokines and increased oxidative damage (Molteni et al., 2013; Tomaz et al., 2014; Zhu et al., 2015; Sulakhiya et al., 2016) . The depressive-like behaviors induced by administration of LPS, such as hypoactivity in the force swimming test and the tail suspension test, can be reversed by antidepressant treatments (Yirmiya, 1996; Ohgi et al., 2013) . In this study, we chose single LPS administration as animal model of depression to evaluate acute therapeutic effects of drugs on inflammatory induced depression. If the drug has the acute therapeutic effect, chronic LPS injection will be used for assessing long-term therapeutic effect of drugs in further study. Grape (Vitis vinifera) is one of the most widely consumed fruits worldwide and grape seed extract consists of ∼90% proanthocyanidins and 7% other polyphenols (flavonoids) (Peng et al., 2005) . Proanthocyanidin is a kind of phenolic product (oligonols are catechin-type monomers, dimmers and trimers, as well as oligomeric proanthocyanidins) present in plant. Experimental and clinical studies have shown that proanthocyanidin has a variety of pharmacological effects, including potent anti-inflammatory and antioxidant effect (Preuss et al., 2000; Uchida et al., 2008; Sato et al., 2001) . Recently, a growing number of studies have found that the proanthocyanidin in grape seed extract possess strong anti-inflammatory activity and would be a potential therapeutic agent for some neuroinflammatory diseases, such as mood disorders and Alzheimer's disease (Aruoma et al., 2006; Mazzio et al., 1998; Xu et al., 2005) .
In the present study, we aimed to investigate the ability of proanthocyanidin to modulate depressive like and anxiety like behaviors of LPS-treated mice. In addition, we measured the expressions of NF-κB, pro-inflammatory cytokines, iNOs and TNFα in the three important brain regions, PFC, amygdala and hippocampus, which are implicated in important behavioral functions, such as emotion, motivation, learning and memory (Butterweck et al., 2002; Rosen et al., 2015) to further confirm the participation of neuroinflammatory in proanthocyanidin treatment.
Materials and methods

Animals
Six-week-old male ICR (Institute of Cancer Research) mice (20-22 g) were obtained from the Shanghai Animal Center, Chinese Academy of Sciences. Upon arrival, the mice were group-housed four per cage and acclimatized to a colony room with controlled ambient temperature (22 ± 1°C), humidity (50 ± 10%) and a light/dark cycle (12:12 h, lights on 7:00 AM). All experiments were conducted in accordance with the National Institutes of Health Guide for Care and Use of Laboratory Animals (Publication No. 85-23, revised 1985) , and approved by the Wenzhou Medical College Committee on Animal Care and Use.
Experimental protocols
Proanthocyanidin (95%) was purchased from Tianjin Jianfeng Natural Product R & D Co., Ltd (Tianjin, China), which contained catechin-type monomers and oligomeric proanthocyanidin (60-80% oligomers), the easily absorbed forms. Proanthocyanidin was dissolved in 0.5% sodium carboxymethylcellulose (CMC-Na). For acute inflammation experiment, mice were received vehicle (CMC-Na) or proanthocyanidin (20, 40, 80 mg/kg, p.o.) for 7 consecutive days before LPS injection. LPS (Sigma, catalogue number:L2880) was dissolved in sterile saline, mice injected with saline or LPS (0.83 mg/kg) after 1 h proanthocyanidin administration on the 7th day (Fig. 1) . The dose of LPS used was selected based on previous studies (O 'Connor et al., 2009; Sulakhiya et al., 2016) . Mice were randomly segregated into six groups: control, control + proanthocyanidin (dose in 80 mg/kg), LPS-treated, LPS + proanthocyanidin (dose in 20, 40, 80 mg/kg). Each group contains 2 subgroup (n = 10 in each subgroup), one is used for evaluating depressive behavior, the other is for anxiety behavior test. The behavior tests were assessed 24 h following injection of saline or LPS. All animals (n = 120) received locomotor activity test before depressive or anxiety behavioral tests. Furthermore, the effect of single acute proanthocyanidin administration on locomotor activity in LPS and control mice were tested in another independent experiment.
Locomotor activity
The assessment of locomotor activity was carried out as previously described Xi et al., 2016) . Mice was placed in a square chamber which was connected to photoelectric cells with light beams passing through the chamber for 15 min. During this period, number of light beam breaks was recorded. Mice were performed a training session for 5 min (pre-test), and then locomotion counts were recorded during the 10 min testing period. Mice were submitted to locomotor activity test 3 h, 6 h and 24 h after LPS injection.
Forced swimming test
Forced swimming test (FST) has been used to identify depressive like behavior in animals (Porsolt et al., 1977 (Porsolt et al., , 1978 . Mice (n = 10/ group, different from those used for TST) were submitted to FST after LPS injection at 24 h. Briefly, mice firstly underwent a swimming-stress session for 15 min (pre-test) in a glass cylinder (height: 25 cm; diameter: 10 cm; containing 10 cm of water at 24 ± 1°C). After 24 h, mice were placed into cylinder again for 6 min (test session). The duration that animals remained immobile during a 6-min observation period was recorded. The last 4 min of the 6-min test was scored for the immobility time. Mice was judged to be immobile when it ceased struggling and remained floating motionless in the water, or made only small movements necessary to keep its head above water.
Tail suspension test
The tail suspension test (TST) was based on the method of Steru (Steru et al., 1985) as our previous study . Mice (n = 10/group, different from those used for FST) were submitted to TST 24 h after LPS administration. Animals were suspended 50 cm above the floor by means of an adhesive tape, placed approximately 1 cm from the tip of the tail. The time during which mice remained immobile was quantified during the test period of 6 min.
Marble-burying test
Marble-burying test was carried out as previously described (Yu et al., 2015) . In brief, mice (n = 10/group, different from those used for depressive behavior tests) were placed individually in a polypropylene cage containing 9 clean glass marbles evenly spaced on 5 cm deep sawdust. Ten minutes later, mice were removed, and the number of marbles at least one-half buried in the sawdust was recorded. Mice were submitted to marble-burying test 24 h after LPS injection.
Elevated plus maze test
The elevated plus maze test was carried out as previously described (Luo et al., 2014) . In brief, animals (n = 10/group, different from those used for depressive behavior tests) were placed on the apparatus of an elevated platform, which consists of two open arms, two closed arms and a central platform. In the beginning of the test, mice were located (20, 40, 80 mg/kg, p.o.) or vehicle (carboxymethylcellulose sodium, CMC-Na, p.o.) for 7 days. LPS or vehicle were injected on day 7 after proanthocyanidin treatment, then behavior tests were done at 24 h after LPS injection. Animals were sacrificed immediately after behavior test for neurochemical analysis. PRO: proanthocyanidin. on the central platform facing open arm. Number of entries, total time spent in the closed and open arms were respectively quantified during a 10-min period using video tracking software (JZZ98, Institute of Materia Medica, Chinese Academy of Medical Sciences, China). Mice were submitted to elevated plus maze test 24 h after LPS injection.
Quantitative real-time RT-PCR
Mice were sacrificed after behavior test and their brains were removed quickly to dissect out hippocampus, PFC and amygdala. The brain regions of each mouse were examined separately. The tissues were stored at −80°C until homogenization. Total cellular RNA was isolated using Trizol reagent (Trizol Invitrogen) according to the manufacturer's protocol and RNA (1 mg) was reverse transcribed using MJ MiniTM Gradient Thermal Cycler (Bio-Rad, Hercules CA, USA). RNA concentration was determined using a spectrophotometer (BioRad. Labs) at 260 nm. The PCR reaction was performed using iCycler Real-Time PCR machine (Bio-Rad, Hercules CA, USA). SYBR Green (iQ SYBR Green supermix reagent, Bio-Rad) was added to each sample at a concentration of 50 nmol/L. Protocol of the real-time PCR was as follows: initial denaturation at 95°C for 10 min, followed by 40 cycles at 95°C for 10 s, 58°C for 30 s. At the end of the PCR reaction, a melting curve was obtained by holding at 95°C for 15 s, cooling to 60°C for 1 min, and then heating slowly at 0.5°C/s until 95°C. The primers: iNOS: Forword (5′-CCT CCT CCA CCC TAC CAA GT-3′); Reverse (5′-CAC CCA AAG TGC TTC AGT CA-3′); COX-2: Forword (5′-TGG GTG TGA AAG GAA ATA AGG A-3′); Reverse (5′-GAA GTG CTGGGC AAA GAA TG-3′); β-actin: Forword (5′-TGG AAT CCT GTG GCATCC ATG AAA C-3′); Reverse (5′-AA AAC GCA GCT CAG TAA CAGTCC G-3′). PCR products were amplified in the real-time PCR machine followed by melt curve analysis and gel electrophoresis to verify specificity and purity of product.
Determination of iNOS and COX-2 levels
The tissue samples were lysed with RIPA lysis buffer (Upstate Chemicon, Temecula, CA) containing protease and phosphatase inhibitors (Pierce Biotechnology, Rockford, IL) and centrifuged at 13,000 rpm for 30 min. The supernatant was assayed for total protein concentrations using BCA assay kit (Thermo Scientific, Rockford, IL). Samples were separated using 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels, and the separated proteins were transferred onto polyvinylidene difluoride membranes. Blots were then incubated in blocking buffer for 2 h at room temperature, washed in tris-buffered saline with 0.1% Tween 20 (TBST), and incubated with anti-iNOS (1:400, sc-7271) or anti-COX-2 (1:400, sc-1747) (Santa Cruz Biotechnologies, CA, USA) for 12 h at 4C. After washing, the blots were incubated with the secondary antibodies (IRDye 800CW Gt Anti-Mouse lgG (H + L) or IRDye 700CW Gt anti-Rabbit lgG (H + L), 1:10000) for 1 h at room temperature. The detection quantification of specific bands was carried out using a fluorescence scanner (Odyssey Infrared Imaging System, LI-COR Biotechnology, South San Francisco, CA) at 700 nm and 800 nm wave lengths.
2.10. Determination of IL-1β, IL-6, NF-κB p65and TNF-α levels Levels of brain IL-1β, IL-6, NF-κB p65 and TNF-α were measured by specific ELISA kit (R & D system Inc Minneapolis, MN, USA). Briefly, serial dilutions of protein standards and samples were added to 96-well ELISA plates, followed by biotinylated anti-antibody. Then the prepared solution of avidin, horseradish peroxidase-conjugated complex was added after rinsing with wash buffer. The reaction was stopped by the stopping solution and the absorbance of IL-1β, IL-6 and TNF-α was read at 450 nm. Differently, the optical density of NF-κB p65 was detected in a microplate reader at 405 nm.
Statistical analysis
Results were presented as the mean ± S.E.M. All data were carried out by one-way analysis of variance (ANOVA), followed by post hoc Tukey test. Differences were considered statistically significant if p < 0.05.
Results
Effect of proanthocyanidin on locomotor activity in LPS mice
In order to eliminate the excitatory or inhibitory effects of LPS and proanthocyanidin on behavior test, the locomotion counts were analyzed before depression or anxiety behavior test. As shown in Fig. 2A , locomotion counts were decreased when compared with control group after LPS injection at 3 h and 6 h [F (3,36) = 3.45, p < 0.05]. However, locomotion counts decrease disappeared and recovered at 24 h after LPS administration, indicating that LPS did not affect the locomotor activity only after 24 h LPS treatment. Additionally, different doses of proanthocyanidin did not affect the locomotion counts, indicating the safety of proanthocyanidin (Fig. 2B) .
Effect of proanthocyanidin on depressive like behavior in LPS mice
Effect of proanthocyanidin on depressive like behavior in LPS mice was assessed by FST and TST[F (5,54) = 9.168, p < 0.001 for FST; F (5,54) = 7.88, p < 0.001 for FST]. Compared with saline group, LPStreated groups induced the significant increase in the immobility time of FST (p < 0.001). However, treatment with proanthocyanidin (40 and 80 mg/kg, p.o.) significantly abolished the adverse effect of LPS (p < 0.05 and p < 0.01, Fig. 3A ), Among these groups, the decrease of immobility time of FST at maximal effect was achieved by 80 mg/kg of proanthocyanidin pretreatment for 7 days (p < 0.01).
Similar results were found in the TST. Among all groups, LPS treatment increased the mice immobility time of TST significantly (p < 0.001), and proanthocyanidin (40 and 80 mg/kg, p.o.) treatment reversed these phenomenons (p < 0.05 and p < 0.01, Fig. 3B) , with the 80 mg/kg of proanthocyanidin treatment group showed the lowest Brain Research Bulletin 135 (2017) 40-46 immobility time. Additionally, no changes of immobility time in FST and TST were observed after proanthocyanidin pre-treatment in normal mice.
Effect of proanthocyanidin on anxiety like behavior in LPS mice
The effect of proanthocyanidin on anxiety like behavior in LPS mice was assessed by marble-burying test and elevated plus maze test (Fig. 4) . In the marble-burying test, one-way ANOVA showed significant changes in the buried marble numbers between the groups [F (5,54) = 4.987, p < 0.01]. There had no significant changes of buried marble numbers were observed in LPS-treated group compared with control group, however, the reduction of buried marble numbers were observed in 80 mg/kg proanthocyanidin-treated control group and 80 mg/kg proanthocyanidin-treated LPS group (p < 0.05 and p < 0.05, Fig. 4A ).
In the elevated plus maze test, as shown in Fig Fig. 4D ).
Effect of proanthocyanidin on LPS-induced NF-κB activation in the hippocampus, PFC and amygdala
As presented in Fig. 5 , the phosphorylation of NF-κB p65 significantly increased in the hippocampus, PFC and amygdala in the LPSinduced mice when compared to the control mice [F (5,30) = 10.72, p < 0.001 for hippocampus, F (5,30) = 8.071, p < 0.001 for PFC and F (5,30) = 5.498, p < 0.01 for amygdala]. Pretreatment with proanthocyanidin (80 mg/kg, p.o.) suppressed LPS-increased NF-κB p65 phosphorylation level in the hippocampus (p < 0.01), PFC (p < 0.05) and amygdala (p < 0.05). (Fig. 7A1 and B1 ). Among these three parts of brain, hippocampus showed the highest expressions of iNOS and COX-2, as well as the phosphorylation of NF-κB p65, which might imply that hippocampus activation was more sensitive to the LPS. Furtherly, proanthocyanidin treatment reversed the expressions of iNOS and COX-2 in the hippocampus, PFC and amygdala ( Fig. 7A2 and  B2 ).
Effect of proanthocyanidin on pro-inflammatory cytokines levels in the hippocampus, PFC and amygdala
Tables 1-3 presented the expressions of IL-1β, IL-6 and TNF-α followed by proanthocyanidin treatment in the hippocampus, PFC and amygdala. LPS administration significantly evoked the expressions of IL-1β, IL-6 and TNF-α in the hippocampus [F (5,54) = 4.251, p < 0.01 for IL-1β, F (5,54) = 8.65, p < 0.001 for IL-6, [F (5,54) = 3.94, p < 0.01 for TNF-α, Table 1 ], PFC (F (5,54) = 3.742), p < 0.01 for IL-1β, F (5,54) = 3.614, p < 0.01 for IL-6, F (5,54) = 3.224, p < 0.01 for TNF-α, Table 2 ] and amygdala [F (5,54) = 4.025, p < 0.01 for IL-1β, F (5,54) = 3.826, p < 0.01 for IL-6, F (5,54) = 3.47, p < 0.01 for TNF-α, Table 3 ], as compared with control group. Whereas, these increases were reversed by pretreatment with proanthocyanidin in the hippocampus (p < 0.01 for IL-1β, p < 0.05 for IL-6, p < 0.05 for TNF-α), PFC (p < 0.05 for IL-1β, p < 0.05 for IL-6, p < 0.01 for TNF-α) and amygdala (p < 0.05 for IL-1β, p < 0.05 for IL-6, p < 0.01 for TNF-α).
Discussion
The present study demonstrated that proanthocyanidin was able to Fig. 6 . Effect of proanthocyanidin on the iNOS (A) and COX-2 (B) mRNA expression in the hippocampus, PFC and amygdala in mice. Mice were administered vehicle or proanthocyanidin (20, 40, 80 mg/kg, p.o.) for 7 days before LPS treatment. At 24 h after LPS administration, hippocampus, PFC o ramygdala extracts were subjected to real-time PCR analysis. β-actin was used as an internal control. Values were the mean ± S.E.M. with 6 mice in each group. *** P < 0.001 vs. the vehicle-treated control group. # P < 0.05 and ## P < 0.01 vs. vehicle-treated LPS group. Fig. 7 . Effect of proanthocyanidin on the iNOS and COX-2 expression in the hippocampus and PFC in mice. The blot of COX-2 (A1) and iNOS (B1) expression in these brain regions shown is a representative of results obtained from six separate experiments. Lane 1: vehicle-treated group; Lane 2: 80 mg/kg proanthocyanidin treated control group; Lane 3: vehicle-treated LPS group; Lane 4: 20 mg/kg proanthocyanidin; Lane 5: 40 mg/kg proanthocyanidin; Lane 6: 80 mg/kg proanthocyanidin. Western blot products of COX-2 (A2) and iNOS (B2) were quantified by densitometric scanning and protein expression was normalized relative to the steadystate expression of β-actin used as internal control. Values were the mean ± S.E.M. with 6 mice in each group. ** P < 0.01 vs. the vehicle-treated control group. # P < 0.05 vs. the vehicle-treated LPS group. IL-1β IL-6 TNF-α Control 7.2 ± 1.0 7.0 ± 1.1 7.5 ± 1.2 PRO 80 8.2 ± 1.1 7.9 ± 1.3 8.0 ± 1.6 LPS 14.1 ± 2.0** 15.3 ± 1.6*** 15.1 ± 1.4** PRO + LPS 20 12.9 ± 1.6 12.1 ± 2.5 10.9 ± 1.2 40 10.2 ± 1.3 # 11.2 ± 1.7 9.7 ± 1.3 80 8.7 ± 1.5 ## 9.2 ± 1.3 # 7.9 ± 0.9 # Values are expressed as mean ± S.E.M. for 10 mice in each group. Data analysis was performed using Dunnett's t-test. ** P < 0.01 and *** P < 0.001 vs. the control group # P < 0.05 and ## P < 0.01 vs. the LPS treated group. PRO: proanthocyanidin; LPS: lipopolysaccharide. Brain Research Bulletin 135 (2017) [40] [41] [42] [43] [44] [45] [46] prevent LPS-induced behavioral alterations, such as depressive like behavior and anxiety like behavior. This antidepressant-like and anxiolytic effect were accompanied by the normalization of LPS-induced inflammatory mediators (i.e., IL-1β, IL-6 and TNF-α) in brain, as well as iNOS and COX-2 expression via the modulation of NF-κB activation in the brain. LPS administration is widely used in animal model of inflammationassociated depression in rodents (Mello et al., 2013) . Some researches found that, depressive like behavior was present after LPS injection at 24 h, without the confounding effects of sickness behaviors in mice (O'Connor et al., 2009; Frenois et al., 2007; Henry et al., 2008) . Interestingly, the locomotor activity test in our study showed that locomotion counts were decreased after LPS injection at 3 h and 12 h, whereas this decrease was disappeared at 24 h after LPS administration, which was consistant with in with previous studies.
X. Jiang et al.
In this project, FST and TST were used to evaluate depressive like behaviors in LPS-induced mice. The results implied that LPS administration decreased the immobility time in TST and FST without changing spontaneous locomotor activity. While the pre-treatment with proanthocyanidin reversed these immobility time decreases in TST and FST, suggesting that proanthocyanidin had the potential in antidepressantlike activity in LPS-induced depression animal model (Fig. 3) .
The anxiety like behavior in marble-burying test and elevated plus maze test were performed to further study the role of LPS in mice and the functions of proanthocyanidin in LPS-induced mice. In anxiety like behaviors, there had no statistical differences observed between LPS and control groups in anxiety-related parameters, such as buried marble numbers, spent time in open/close arm. LPS group showed the similar levels of anxiety-related parameters with control group. These results were agreed with the previous study that there also had no differences between LPS and control groups in parameters related to anxiety (time spent in central and peripheral zones in an open field) (Kirsten et al., 2015) , which indicated that LPS might not involve in anxiety levels.
Compared with control group, acute proanthocyanidin treatment without LPS administration showed an anxiolytic effect (Fig. 4) . Similar to our results, Moreira's study also found that acute proanthocyanidin treatment increased open arm entries in elevated plus maze test, suggesting it may process acute anxiolytic effect (Moreira et al., 2010 ). Proanthocyanidin's anxiolytic function were also observed in LPS treated mice, interestingly, our data showed that LPS do not lead to anxiety behavior, suggesting behavioral changes in proanthocyanidin treated LPS mice may due to proanthocyanidin's acute anxiolytic function, but it need to be further demonstrated by a following study. The activation of NF-κB may be a pivotal event in pro-inflammatory signal transduction. Activated NF-κB affects gene transcription of proinflammatory cytokines and neurotoxic mediators, such as IL-1β, IL-6, TNF-α and iNOS (Park et al., 2007; Csaki et al., 2009; Sahu et al., 2014) . Alterations in the function of these genes that induced by NF-κB activation can cause behavioral abnormalities, varying from mood, sleep, learning and memory (Butterweck et al., 2002) . Our data found significant increases in the expression of NF-κB p65 subunit in hippocampus, PFC and amygdala after LPS treatment. However, these increases were reversed by proanthocyanidin treatment, suggesting that the effects of proanthocyanidin on LPS-induced depressive-like behavior might be owing to the inhibition of NF-κB expression in these brain regions.
Furthermore, pro-inflammatory cytokines (IL-1β, IL-6 and TNF-α), the effector of NF-κB, have been known to play important roles in the biological basis of LPS-induced depression (Puntener et al., 2012; Biesmans et al., 2013) . For example, administration of IL-1β into hippocampus could cause depressive-like effects (Wohleb et al., 2011) . The injection of TNF-α as same as IL-1β, could lead to the locomotor activity reduction and sleep disorder (Hayley et al., 1999) . In the present study, we found that IL-1β, IL-6 and TNF-α levels were significantly increased in hippocampus, PFC and amygdala after acute LPS administration. Moreover, the pre-treatment with proanthocyanidin reversed those LPS-induced neuroinflammation. These results suggested that the antidepressant effect of proanthocyanidin may be due to its anti-inflammatory function, especially the inhibition of IL-1β, IL-6 and TNF-α expression in hippocampus, PFC and amygdala.
In addition to proinflammatory cytokines, activation of oxidative and nitrosative pathways are being considered as a promising depressive biomarker (Tomaz et al., 2014; Zlatković and Filipović, 2013) . Inducible nitric oxide synthase (iNOS) is an critical element of NF-kB pathway, as well as a biomarker of depression, can generate nitric oxide (NO). In line with the previous studies, we found that mRNA and protein expressions of iNOS were increased in hippocampus, PFC and amygdala of LPS-treated mice, and proanthocyanidin administration reversed all of these increases in these brain regions. Besides, COX-2, another critical element of NF-κB pathway, is associate with stress related diseases, such as depression and anxiety (Girotti et al., 2011; Tomaz et al., 2014) . Our studies showed that proanthocyanidin treatment significantly decreased the LPS-induced overexpression of COX-2 in hippocampus, PFC and amygdala. Taken together, these results demonstrated that the anti-inflammatory function, especially the inhibition on the NF-κB pathway, could be contribute to the antidepressant effect of proanthocyanidin.
In conclusion, LPS administration induced depressive-like behavior in mice via neuroinflammatory pathway. Proanthocyanidin has the great potential to reverse the depressive-like behavior in LPS-induced depression model of mice. The antidepressant effect of proanthocyanidin may be partially by attenuating pro-inflammatory mediators, inhibiting the expressions of the proinflammatory cytokines, iNOS and COX-2 in the hippocampus, PFC and amygdala, which largely by suppressing the NF-κB signaling pathway.
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